
Read More
Buyback Alert: Divis Laboratories Competitor Approves Rs 800 Crore Share Bu...
Aurobindo Pharma approves Rs 800 crore buyback at Rs 1,475 per share, representing 0.93 per cent of ...

Aurobindo Pharma approves Rs 800 crore buyback at Rs 1,475 per share, representing 0.93 per cent of ...

The facility in question, Unit-V, is an active pharmaceutical ingredient (API) manufacturing site op...

Are you looking to trade breakout stocks? Checkout this article that lists top stocks witnessing a s...

Are you looking for a strong breakout setup? Checkout this article that lists top stocks witnessing ...

Despite being a weak market on Friday, there were few penny stocks that touched 5 per upper circuit ...

Are you looking to trade a solid breakout stock? Checkout our article that lists top stocks that hav...

In such a weak market, its strong price-volume breakout kept the bulls in the small-cap sector busy....

On Tuesday, investors' chose to book profits on the day ahead of RBI policy outcome. Meanwhile, the ...

For the second consecutive session in the week, the equity markets traded in green and ended the tra...

The stock of Aurobindo Pharma is extremely bullish today and has surged nearly 2 per cent despite tu...